Bio-Techne Corp TECH
72.61
0.04
0.06%
as of 25 Sep
- Market cap
- $11.4B
- P/E
- 62.1×
Follow TECH
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 9.03% | 5.34% | 3.97% | 3.80% |
+8 more TTM periods Free account |
|
| 7.07% | 4.22% | 3.12% | 2.96% | ||
ROIC |
7.70% | 4.63% | 3.48% | 3.24% | |
Return on Tangible Assets |
22.38% | 14.27% | 11.09% | 11.06% | |
Average Days of Receivables |
65.06 | 64.68 | 55.43 | 55.17 | |
Free Cash Flow per Share |
1.69 | 1.72 | 1.43 | 1.44 | |
Free Cash Flow |
263.22 | 269.60 | 223.02 | 224.06 | |
Capital Expenditures |
(28.85) | (25.26) | (26.30) | (27.20) | |
Piotroski F-Score |
8.00 | 6.00 | 6.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
11.35% | 11.82% | 10.20% | 10.42% | |
Accounts Receivable Turnover |
5.74 | 5.36 | 6.04 | 5.97 | |
Accounts Payable Turnover |
16.00 | 15.39 | 14.24 | 13.66 | |
Inventory Turnover |
2.16 | 2.16 | 2.15 | 2.17 | |
Average Days of Payables |
23.43 | 20.21 | 22.68 | 26.12 | |
Days of Inventory on Hand |
171.76 | 173.05 | 177.35 | 176.01 | |
Tax Rate |
(0.24) | (0.26) | (0.29) | (0.27) | |
Research and Development Expense of Revenue |
7.80% | 8.00% | 8.06% | 8.21% | |
Selling, General and Administrative Expense of Revenue |
37.23% | 44.26% | 47.53% | 48.13% | |
Share Based Compensation of Revenue |
3.40% | 3.36% | 3.42% | 3.48% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.61 | 2.69 | 3.07 | 3.22 | |
Depreciation/Fixed assets |
0.42 | 0.43 | 0.44 | 0.44 | |
Capex/Depreciation |
(0.30) | (0.25) | (0.25) | (0.26) | |
Revenue per Share |
7.79 | 7.75 | 7.80 | 7.83 | |
Operating CF per Share |
1.87 | 1.89 | 1.60 | 1.62 | |
Capex per Share |
(0.18) | (0.16) | (0.17) | (0.17) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | |
Net Profit Margin |
14.97% | 9.05% | 6.67% | 6.41% |
Columns are period end dates